Centre for Advanced Studies in Zoology, University of Rajasthan, Jaipur 302 004, India.
J Ethnopharmacol. 2010 Feb 3;127(2):286-91. doi: 10.1016/j.jep.2009.11.007. Epub 2009 Nov 13.
The manuscript is one of the series of attempts in authenticating scientific documentation of the seeds of Carica papaya being traditionally used for contraception.
To establish safety of the methanol sub-fraction (MSF) of the seeds of Carica papaya as a male contraceptive following long term oral treatment.
MSF was administered orally to albino rats at multiples of contraceptive dose (CD) at 50 (1x), 100 (2x), 250 (5x) and 500 (10x)mg/kg body weight daily for 52 weeks. Body weight, organs weight, morbidity, mortality, clinical chemistry, sperm analysis, histopathology and serum testosterone were evaluated to assess the safety and contraceptive efficacy.
MSF treatment at various dose regimens, daily for 52 weeks did not show significant changes in body weight, organs weight, food and water intake and pre-terminal deaths compared to those of control animals. Sperm count and viability in 50mg/kg body weight treated animals and the weight of epididymis, seminal vesicle and prostate of all the treated animals showed significant reduction compared to control. Cauda epididymal spermatozoa of 50mg/kg body weight treated animals were immotile. Azoospermia was observed in 100, 250 and 500 mg/kg body weight treated animals. Serum clinical parameters, serum testosterone and histopathology of vital organs were comparable to those of control animals. Histology of testis revealed adverse effects on the process of spermatogenesis, while the histology of epididymis, seminal vesicles and ventral prostate showed no changes compared to control.
The long term daily oral administration of MSF affects sperm parameters without adverse side effects and is clinically safe as a male contraceptive.
本文是一系列尝试中的一篇,旨在验证木瓜籽作为传统避孕方法的科学文献。
确定木瓜籽甲醇提取物(MSF)作为长期口服避孕药的安全性。
将 MSF 以避孕剂量(CD)的倍数(50 倍(1x)、100 倍(2x)、250 倍(5x)和 500 倍(10x))分别给白化大鼠口服,每天一次,持续 52 周。评估体重、器官重量、发病率、死亡率、临床化学、精子分析、组织病理学和血清睾酮,以评估安全性和避孕效果。
与对照组相比,不同剂量方案(52 周每天)的 MSF 治疗未显示体重、器官重量、食物和水摄入以及终端前死亡率的显著变化。50mg/kg 体重治疗动物的精子计数和活力以及所有治疗动物的附睾、精囊和前列腺重量均显著降低。50mg/kg 体重治疗动物的尾部附睾精子不动。100、250 和 500mg/kg 体重治疗动物出现无精症。血清临床参数、血清睾酮和重要器官组织病理学与对照组相似。睾丸组织学显示对精子发生过程有不良影响,而附睾、精囊和前列腺腹侧组织学与对照组相比无变化。
长期每日口服 MSF 会影响精子参数,但无不良反应,作为男性避孕药在临床上是安全的。